Tempus AI announced its acquisition of Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies. Deep 6 AI is integrated with over 750 provider site locations, spanning more than 30 million patients.
Deep 6 AI specializes in de-risking clinical trials, accelerating recruitment, and generating real-world evidence with speed and precision. Its AI-powered software matches patients to clinical trials by mining real-time structured and unstructured electronic medical record data across a broad ecosystem.
This acquisition broadens Tempus’s reach by adding more providers to its platform and enhances its ability to deploy critical applications like Next, which helps physicians close care gaps, and TIME, which assists patients in finding potentially life-saving clinical trials. The integration infrastructure of Deep 6 is well-suited to complement Tempus’s existing connectivity efforts.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.